GMO US Value ETF
GMOV
19 hedge funds and large institutions have $25.4M invested in GMO US Value ETF in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 2 reducing their positions, and 2 closing their positions.
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
300% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 2
46% more funds holding
Funds holding: 13 → 19 (+6)
34% more capital invested
Capital invested by funds: $19M → $25.4M (+$6.48M)
3.59% more ownership
Funds ownership: 28.75% → 32.33% (+3.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.71M |
| 2 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$1.55M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$937K |
| 4 |
FEG
Fund Evaluation Group
Cincinnati,
Ohio
|
+$841K |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$670K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
-$1.26M |
| 2 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
-$784K |
| 3 |
RAS
RPS Advisory Solutions
Louisville,
Kentucky
|
-$484K |
| 4 |
AIM
Aspen Investment Management
Grand Rapids,
Michigan
|
-$34.9K |
GMOV Hedge Fund Activity: Q1 2026 in Review
19 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in GMO US Value ETF (GMOV) for Q1 2026, worth a combined $25.4M — up 34% from $19M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new GMOV positions and 2 closed out — a net gain of 7 holders — while 8 added to existing stakes and 2 trimmed.
The largest buyer was Envestnet Asset Management, adding an estimated $1.71M. The largest seller was Cerity Partners, cutting an estimated $1.26M.
- 19 institutional investors held GMO US Value ETF (GMOV) as of Q1 2026, up from 13 in Q4 2025.
- Funds reported $25.4M of GMO US Value ETF stock for Q1 2026, up 34% quarter-over-quarter.
- 9 funds opened new GMO US Value ETF positions in Q1 2026 and 2 closed out, a net change of +7 holders.
- The largest GMO US Value ETF buyer in Q1 2026 was Envestnet Asset Management, an estimated $1.71M added.
- The largest GMO US Value ETF seller in Q1 2026 was Cerity Partners, an estimated $1.26M sold.
Based on aggregated 13F filings for Q1 2026.